Epigenetic targeting of ovarian cancer stem cells Y Wang, H Cardenas, F Fang, S Condello, P Taverna, M Segar, Y Liu, ... Cancer research 74 (17), 4922-4936, 2014 | 164 | 2014 |
FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling H Huang, Y Wang, M Kandpal, G Zhao, H Cardenas, Y Ji, A Chaparala, ... Cancer research 80 (16), 3200-3214, 2020 | 162 | 2020 |
Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis Y Wang, G Zhao, S Condello, H Huang, H Cardenas, EJ Tanner, JJ Wei, ... Cancer research 81 (2), 384-399, 2021 | 154 | 2021 |
Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer AR Özeş, Y Wang, X Zong, F Fang, J Pilrose, KP Nephew Scientific reports 7 (1), 894, 2017 | 131 | 2017 |
The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer F Fang, J Munck, J Tang, P Taverna, Y Wang, DFB Miller, J Pilrose, ... Clinical cancer research 20 (24), 6504-6516, 2014 | 128 | 2014 |
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells Y Tan, J Li, G Zhao, KC Huang, H Cardenas, Y Wang, D Matei, JX Cheng Nature communications 13 (1), 4554, 2022 | 107 | 2022 |
IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells Y Wang, X Zong, S Mitra, AK Mitra, D Matei, KP Nephew JCI insight 3 (23), 2018 | 102 | 2018 |
A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer NG Nwani, S Condello, Y Wang, WM Swetzig, E Barber, T Hurley, D Matei Cancers 11 (4), 502, 2019 | 61 | 2019 |
Decitabine reactivated pathways in platinum resistant ovarian cancer F Fang, Q Zuo, J Pilrose, Y Wang, C Shen, M Li, P Wulfridge, D Matei, ... Oncotarget 5 (11), 3579, 2014 | 61 | 2014 |
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids G Zhao, Y Tan, H Cardenas, D Vayngart, Y Wang, H Huang, R Keathley, ... Proceedings of the National Academy of Sciences 119 (41), e2203480119, 2022 | 36 | 2022 |
FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway Y Zhang, Y Wang, G Zhao, EJ Tanner, M Adli, D Matei The Journal of Clinical Investigation 132 (10), 2022 | 23 | 2022 |
Metabolic dependencies and targets in ovarian cancer Y Zhang, Y Wang, G Zhao, S Orsulic, D Matei Pharmacology & Therapeutics 245, 108413, 2023 | 22 | 2023 |
The ratio of toxic-to-Nontoxic mirnas predicts platinum sensitivity in ovarian cancer M Patel, Y Wang, ET Bartom, R Dhir, KP Nephew, D Matei, AE Murmann, ... Cancer research 81 (15), 3985-4000, 2021 | 16 | 2021 |
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer LE Sima, S Chen, H Cardenas, G Zhao, Y Wang, C Ivan, H Huang, ... Journal for immunotherapy of cancer 9 (9), 2021 | 15 | 2021 |
Relationships among Rubus (Rosaceae) Species used in Traditional Chinese Medicine Y Wang | 11 | 2011 |
Biology-driven therapy advances in high-grade serous ovarian cancer Y Wang, AJ Duval, M Adli, D Matei The Journal of Clinical Investigation 134 (1), 2024 | 9 | 2024 |
N6-methyladenosine RNA modifications regulate the response to platinum through nicotinamide N-methyltransferase H Huang, G Zhao, H Cardenas, AF Valdivia, Y Wang, D Matei Molecular cancer therapeutics 22 (3), 393-405, 2023 | 7 | 2023 |
DOT1 L regulates ovarian cancer stem cells by activating β-catenin signaling Y Zhang, Y Wang, A Valdivia, H Huang, D Matei Molecular Cancer Research 21 (2), 140-154, 2023 | 5 | 2023 |
Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance Y Wang, AE Calvert, H Cardenas, JS Rink, D Nahotko, W Qiang, ... Advanced Science 11 (13), 2305212, 2024 | 3 | 2024 |
Abstract A57: Platinum induces IL-6-signaling mediated activation of ALDH1A1 and enriches the cancer stem cell population in ovarian cancer. Y Wang, AK Mitra, KP Nephew Clinical Cancer Research 22 (2_Supplement), A57-A57, 2016 | 3 | 2016 |